Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
7
88%
Ph phase_1
1
13%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(5)
Terminated(1)
Other(2)

Detailed Status

Completed5
unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (12.5%)
N/A7 (87.5%)

Trials by Status

completed563%
unknown225%
withdrawn113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
8